These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 2977981

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Effects of 2 single oral doses of mesoglycan on the coagulation-fibrinolysis system in man. A pharmacodynamic study].
    Messa G, Blardi P, La Placa G, Puccetti L, Ghezzi A.
    Recenti Prog Med; 1995; 86(7-8):272-81. PubMed ID: 7569283
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Sulodexide oral administration influences blood viscosity and fibrinolysis.
    Crepaldi G, Rossi A, Coscetti G, Abbruzzese E, Calveri U, Calabrò A.
    Drugs Exp Clin Res; 1992; 18(5):189-95. PubMed ID: 1490434
    [Abstract] [Full Text] [Related]

  • 5. Mesoglycan exerts its fibrinolytic effect through the activation of annexin A2.
    Belvedere R, Morretta E, Pessolano E, Novizio N, Tosco A, Porta A, Whiteford J, Perretti M, Filippelli A, Monti MC, Petrella A.
    J Cell Physiol; 2021 Jul; 236(7):4926-4943. PubMed ID: 33284486
    [Abstract] [Full Text] [Related]

  • 6. [Mesoglycan and fibrinolysis: therapeutic activity of oral mesoglycan in venous thrombosis. A short-term clinical, biological and instrumental study].
    Vittoria A, Cappelli R, Messa GL, Auteri A.
    Minerva Med; 1986 Oct 20; 77(40):1867-72. PubMed ID: 2946002
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Retinoic acid enhances fibrinolytic activity in-vivo by enhancing tissue type plasminogen activator (t-PA) activity and inhibits venous thrombosis.
    van Giezen JJ, Boon GI, Jansen JW, Bouma BN.
    Thromb Haemost; 1993 Apr 01; 69(4):381-6. PubMed ID: 8497851
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Fibrinolytic system of animals repeatedly and chronically administered plasminogen tissue activator].
    Shimonaeva EE, Liutova LV, Andreenko GV.
    Vopr Med Khim; 1981 Apr 01; 27(6):823-8. PubMed ID: 7199779
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Use of a minor fibrinolytic drug (mesoglycan) in phlebitis].
    Scondotto G, De Fabritiis A, Guastarobba A, Amato AC, Filippini M.
    Minerva Med; 1984 Jul 14; 75(28-29):1733-8. PubMed ID: 6236381
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The effect of dexamethasone on tissue fibrinolytic system in male and female rats.
    Tsantarliotou M, Taitzoglou I, Kokolis N.
    In Vivo; 1999 Jul 14; 13(2):119-24. PubMed ID: 10363166
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.